HUMANISIERTE ODER CHIMÄRE CD3-ANTIKÖRPER

Patent europeic · EP3322727 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3322727
Numer da la dumonda
EP16739459
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-07-2016
Publitgà
23-05-2018
Concedì
31-12-2025
La protecziun finescha il pli tard
13-07-2036
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07K 16/28 (2006.01)
C07K 16/32 (2006.01)
Prioritad
DK 201500414 15.07.2015
DK 201500413 15.07.2015
DK 201500416 16.07.2015
WO PCT/EP2016/050296 08.01.2016
Dumonda PCT
PCT/EP2016/066845 14.07.2016
Publicaziun PCT
WO2017/009442 19.01.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 13-02-2026

    Represchentant inscrit

    Representative
    OFFICE FREYLINGER S.A., c/o Schluep IP Law AG, Falkenplatz 7, 3012 Bern

    Published in Swissreg on 13.02.2026

  3. 31-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 31.12.2025

Partidas

Inventur

RADEMAKER, Rik

3584 CT Utrecht, NL

ALTINTAS, Isil

3584 CT Utrecht, NL

ENGELBERTS, Patrick

3584 CT Utrecht, NL

SCHUURMAN, Janine

1111 CH Diemen, NL

PARREN, Paul

3984 PR Odijk, NL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.